SCHEMBL243721

SCHEMBL243721

O=C(O)/C(O)=C/c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.60
AKR1C1 Q04828 1/20 0.58
CYP2C9 P11712 2/20 0.52
CYP3A4 P08684 1/20 0.52
TP53 P04637 1/20 0.50
HTT P42858 2/20 0.48
ALDH1A1 P00352 4/20 0.48
TSHR P16473 1/20 0.48
RECQL P46063 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
HDAC3 O15379 1/20 0.46
TNKS O95271 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HCAR2 Q8TDS4 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7454012 1.00 AKR1C3 (0.60) AKR1C3AKR1C1CYP2C9CYP3A4TP53
SCHEMBL141612 1.00 AKR1C3 (0.60) AKR1C3AKR1C1CYP2C9CYP3A4TP53
Hydrochloric Acid SCHEMBL15862140 0.97 AKR1C3 (0.58) AKR1C3AKR1C1CYP2C9CYP3A4TP53
Hydrochloric Acid SCHEMBL15862141 0.97 AKR1C3 (0.58) AKR1C3AKR1C1CYP2C9CYP3A4TP53
Methane SCHEMBL1221501 0.97 AKR1C3 (0.58) AKR1C3AKR1C1CYP2C9CYP3A4TP53
SCHEMBL27561113 0.97 AKR1C3 (0.58) AKR1C3AKR1C1CYP2C9CYP3A4TP53
SCHEMBL28307539 0.97 AKR1C3 (0.58) AKR1C3AKR1C1CYP2C9CYP3A4TP53
Ammonia Solution, Strong SCHEMBL28233006 0.95 AKR1C3 (0.56) AKR1C3AKR1C1CYP2C9CYP3A4TP53
Sulfuric Acid SCHEMBL28985900 0.91 AKR1C3 (0.52) AKR1C3AKR1C1CYP2C9CYP3A4TP53
Phenol SCHEMBL15014256 0.91 AKR1C3 (0.52) AKR1C3AKR1C1CYP2C9CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12076316-B2 Levorphanol prodrugs and processes for making and using them ZEVRA THERAPEUTICS INC. 2024-09-03 US claimed
CN-115407010-B Method for identifying active ingredients in edible betel nuts by using wide-range targeted metabonomics technology 中国检验检疫科学研究院 2024-01-23 CN claimed
CN-115407010-A Method for identifying active ingredients in edible areca nuts by utilizing extensive targeted metabonomics technology 中国检验检疫科学研究院 2022-11-29 CN claimed
US-20220096463-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2022-03-31 US claimed
US-11234975-B2 Levorphanol prodrugs and processes for making and using them KEMPHARM, INC. (US) 2022-02-01 US claimed
US-20210002226-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2021-01-07 US claimed
US-20200390757-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2020-12-17 US claimed
WO-2018191474-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM KEMPHARM, INC. (US) 2018-10-18 WO claimed
WO-2018191472-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM KEMPHARM, INC. (US) 2018-10-18 WO claimed
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2017-11-02 US claimed
US-20120142720-A1 Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof KEMPHARM, INC. (US) 2012-06-07 US claimed
EP-2448408-A1 PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF Kempharm, Inc. (US) 2012-05-09 EP claimed
WO-2011002995-A1 PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF KEMPHARM, INC. (US) 2011-01-06 WO claimed
US-20110002991-A1 PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2011-01-06 US claimed
US-6451498-B1 Photosensitive composition ATOTECH DEUTSCHLAND GMBH (DE) 2002-09-17 US claimed
EP-0864119-B1 PHOTOSENSITIVE COMPOSITION ATOTECH DEUTSCHLAND GMBH (DE) 2001-02-14 EP claimed
EP-0864119-A1 PHOTOSENSITIVE COMPOSITION ATOTECH Deutschland GmbH (DE) 1998-09-16 EP claimed
WO-1997020254-A1 PHOTOSENSITIVE COMPOSITION ATOTECH DEUTSCHLAND GMBH (DE) 1997-06-05 WO claimed
EP-0184044-B1 LIGHT-SENSITIVE COMPOSITION, REGISTRATION MATERIAL PREPARED THEREOF, AND PROCESS FOR OBTAINING HEAT-RESISTANT RELIEF IMAGES HOECHST AKTIENGESELLSCHAFT (DE) 1992-01-15 EP claimed
EP-0184044-A2 Light-sensitive composition, registration material prepared thereof, and process for obtaining heat-resistant relief images HOECHST AKTIENGESELLSCHAFT (DE) 1986-06-11 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142720-A1 Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof CYP7A1, CYP2B6, CYP2D6 AKR1C3 689/4885AKR1C1 1409/4885CYP2C9 20/4885
US-20200390757-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRL1, OPRK1 AKR1C3 891/4885AKR1C1 1858/4885CYP2C9 147/4885
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 AKR1C3 382/4885AKR1C1 639/4885CYP2C9 37/4885
US-12076316-B2 Levorphanol prodrugs and processes for making and using them OPRM1, OPRL1, OPRK1 AKR1C3 891/4885AKR1C1 1858/4885CYP2C9 147/4885
US-20110002991-A1 PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF CYP7A1, CYP2B6, CYP2D6 AKR1C3 706/4885AKR1C1 1428/4885CYP2C9 20/4885
US-11234975-B2 Levorphanol prodrugs and processes for making and using them OPRM1, OPRL1, OPRK1 AKR1C3 891/4885AKR1C1 1858/4885CYP2C9 147/4885
US-20210002226-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRK1, OPRD1 AKR1C3 542/4885AKR1C1 1337/4885CYP2C9 83/4885
US-20220096463-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRL1, OPRK1 AKR1C3 891/4885AKR1C1 1858/4885CYP2C9 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.